Position in ACB
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$176,115
-$13,747 QoQ
Shares Held
63,124
+8.7% QoQ
Ownership
0.100%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#13
of 149 holders
Holding Since
Mar 2020
22 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ACB Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026MACKENZIE FINANCIAL CORP holds $92,574,463 across 16 Drug Manufacturers - Specialty & Generic names. ACB ranks #16 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | NBIX |
Neurocrine Biosciences Inc
|
175,685 | $29,609,949 | |
| 2 | ZTS |
Zoetis Inc.
|
268,075 | $19,263,869 | |
| 3 | IRWD |
Ironwood Pharmaceuticals Inc
|
2,367,493 | $9,967,145 | |
| 4 | VTRS |
Viatris Inc
|
572,287 | $9,087,917 | |
| 5 | UTHR |
UNITED THERAPEUTICS Corp
|
15,849 | $8,587,463 | |
| 6 | CRON |
Cronos Group Inc.
|
1,597,039 | $4,439,768 | |
| 7 | BCRX |
Biocryst Pharmaceuticals Inc
|
347,299 | $3,472,990 | |
| 8 | TEVA |
Teva Pharmaceutical Industries Ltd
|
91,604 | $3,103,543 |
All Filings in ACB
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $176,115 | 63,124 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $189,862 | 58,062 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $235,091 | 55,709 | Shares | Sole | 2026-02-18 | |
| 2025-09-30 | $202,097 | 33,909 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $125,024 | 29,487 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $121,967 | 27,783 | Shares | Sole | 2025-05-07 | |
| 2024-12-31 | $108,387 | 25,503 | Shares | Sole | 2025-05-02 | |
| 2024-09-30 | $144,001 | 24,490 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $112,774 | 24,410 | Shares | Sole | 2024-08-14 | |
| 2023-12-31 | $95,196 | 199,992 | Shares | Sole | 2024-01-30 | |
| 2023-03-31 | $78,845 | 113,121 | Shares | Sole | 2023-04-24 | |
| 2022-12-31 | $102,695 | 111,263 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $99,827 | 81,826 | Shares | Sole | 2022-10-07 | |
| 2022-06-30 | $110,833 | 83,965 | Shares | Sole | 2022-08-10 | |
| 2022-03-31 | $375,576 | 93,894 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $338,373 | 62,546 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $319,600 | 46,185 | Shares | Sole | 2021-11-08 | |
| 2021-06-30 | $341,296 | 37,754 | Shares | Sole | 2021-08-11 | |
| 2021-03-31 | $353,696 | 37,991 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $113,190 | 13,621 | Shares | Sole | 2021-02-10 | |
| 2020-09-30 | $60,082 | 12,921 | Shares | Sole | 2020-11-13 | |
| 2020-03-31 | $17,579 | 19,403 | Shares | Sole | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||